Three-dimensional echocardiographic evaluation of the Fontan conduit for thrombus

Christopher R Mart1

  • 1Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA. christopher.mart@imail.org

Insights

Three-dimensional echocardiography shows promise in detecting or excluding thrombi within the Fontan conduit, a critical step in managing single ventricle congenital heart disease. This advanced imaging may improve patient monitoring and reduce risks associated with clot formation.

Area of Science:

  • Cardiology
  • Medical Imaging
  • Congenital Heart Disease

Background:

  • The Fontan circuit is a palliative procedure for single ventricle congenital heart disease, creating a high-risk environment for thrombus formation.
  • Antithrombotic therapy and monitoring are crucial for patients with Fontan circuits to prevent emboli.
  • Traditional 2D echocardiography has limitations in accurately detecting thrombi within the Fontan conduit.

Observation:

  • This case series evaluated four patients with suspected or potential thrombus in the Fontan conduit using 3D echocardiography.
  • Both 3D transthoracic and 3D transesophageal echocardiography were utilized for imaging the Fontan conduit.
  • The study aimed to assess the efficacy of 3D echocardiography in thrombus detection or exclusion within the Fontan circuit.

Findings:

  • Three-dimensional echocardiography successfully documented or excluded thrombi in all four patients evaluated.
  • The study demonstrated the potential of 3D imaging to visualize the Fontan conduit more effectively than 2D methods.
  • This represents the first case series specifically using 3D echocardiography for Fontan conduit thrombus evaluation.

Implications:

  • Three-dimensional echocardiography may offer enhanced accuracy in detecting or excluding thrombi within the Fontan conduit.
  • Further research is necessary to validate 3D echocardiography as a reliable technique for Fontan conduit assessment.
  • Improved thrombus detection could lead to better management strategies and outcomes for patients with Fontan physiology.
Abstract